Breast Cancer

Article	Citations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	166
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	64
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	42
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society	36
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy	30
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	29
Low-carbohydrate diet score and risk of breast cancer: findings from a prospective cohort study	25
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	23
Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study	22
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances	22
BARD1 and breast cancer genetic predisposition: case–control study and HRD signature analysis	21
Factors associated with post acute care utilization after mastectomy for breast cancer patients	21
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	20
The role of C1orf50 in breast cancer progression and prognosis	20
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial	19
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan	19
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	19
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	19
Exploring a specialized lactylation pattern to predict the prognosis and sensitivity of immunotherapy in breast cancer via machine learning	18
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	17
Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study	17
Emerging roles of KIR2DL4 in cancer immunotherapy	16
Real-world analysis of interstitial lung disease/pneumonitis in Japanese patients with breast cancer receiving trastuzumab deruxtecan	16
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	16
Reevaluating sentinel lymph node biopsy in older adults with T1 HR+/HER2– breast cancer: a SEER competing risk and nomogram study	16

Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	16
Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival	15
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	15
Low-progesterone receptor expression predicts nodal pathological complete response after neoadjuvant chemotherapy in premenopausal patients with ER-positive/HER2-negative breast cancer	15
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions — a first large-scale multi-institutional clinical trial in Japan	15
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutio	14
Safety of radiotherapy in patients undergoing breast reconstruction based on patient-reported outcomes: a multicenter collaborative study	14
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	14
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	14
Prospective randomized-controlled trial: efficacy of 37 °C-preheated thermoplastic elastomer (TPE) bolus in postoperative radiotherapy for breast cancer patients	14
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	14
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	13
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	13
Comparative evaluation of treatment recommendations generated by generative AI and breast cancer specialists for advanced and recurrent breast cancer: a multidimensional assessment of evidence interpr	13
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	13
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	13
Glutaminase (GLS1) gene expression in primary breast cancer	13
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	13
Evaluation of serum microRNA-9-5p expression and its predicted target genes as potential biomarkers for breast cancer	13
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	12
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	12
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	12
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer	12
CT findings of lung injury during breast cancer treatment	12
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	12
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2− advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis	12
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	11
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	11
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	11
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	11
Comparison of three arm-positioning techniques for minimizing motion artifacts in breast magnetic resonance imaging: a prospective volunteer study	11
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	10
Methodological considerations in prognostic modeling for HER2-positive breast cancer with lung metastasis	10
Clinical outcomes of postoperative radiotherapy with regional nodal irradiation excluding internal mammary lymph nodes in breast cancer: a multi-institutional retrospective analysis	10
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	10
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	10
Breast cancer screening guidelines: discrepancies raise concerns about validity	10
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	10
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	10
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	10
Chemotherapy and cognition: a promising start, but mechanistic clarity still needed	10
An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases	10
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017	10
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	10
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	9
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	9
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	9
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	9
HER2-positive apocrine carcinoma of the breast and PIK3CA mutations	9

Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	9
Early outcomes of accelerated partial breast irradiation and dosimetric comparison of volumetric modulated arc therapy and three-dimensional conformal radiotherapy	9
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II–III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03)	9
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	9
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	9
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	9
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	9
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	9
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	8
Functional characterization of BRCA2 variants of uncertain significance identified in Korean breast cancer patients	8
Correction: The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway	8
Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan—a matched cohort study	8
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	8
Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients	8
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	8
The impact of specialist palliative care on healthcare utilization among patients with breast cancer: a nationwide register-based cohort study	8
Performance analysis of screening mammography in Asian women under 40 years	8
Patient satisfaction on prescription refill systems for breast cancer patients in Japan using a digital self-administered survey	8
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	8
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer	8
Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	8
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	8
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	8
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	8
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC	7
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	7
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	7
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	7
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	7
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	7
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	7
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	7
A simple morphometric algorithm based on nuclear atypia features of invasive breast carcinoma: relationship with nuclear grade, Ki-67 level, and hormone receptor status	7
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	7
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	7
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study	7
Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers	7
Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02)	7
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	6
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	6
Management of nausea and vomiting induced by antibody–drug conjugates	6
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	6
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	6
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	6
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	6
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial	6
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	6
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	6
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	6
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	6
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	6
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	6
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	6
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	6
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	6
Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practic	6
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	6
Prospective study of once-daily accelerated partial breast irradiation using 3-dimensional conformal external beam radiotherapy for Japanese women: 12-year outcomes, toxicity, and cosmesis	5
Characterization of gut microbiota dysbiosis in breast cancer patients	5
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	5
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	5
Breast cancer screening rates and influencing factors among LGBTQ groups in Japan	5
Real world experience of intraoperative radiation therapy (IORT) during lumpectomy for early-stage breast cancer: retrospective data from a single large institutional observational study	5
Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer	5
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor reg	5
Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM)	5
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	5
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer	5
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer	5
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study	5
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	5
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients	5
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	5
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	5
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients	5
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery	5

Effects of CBT-based interventions on health outcomes in breast cancer patients: a systematic review and Meta-analysis	5
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses	5
Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?	5
C-type lectin-like domain family 2 (CLEC2D) promotes proliferation and migration of breast cancer and serves as a poor prognostic factor	4
Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study	4
Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study	4
Risk factors associated with molecular subtypes of breast cancer among indian women: a multicentre matched case–control study	4
Prognostic and monitoring value of circulating tumor DNA at multiple clinical time points in breast cancer	4
Acknowledgments to reviewers 2023	4
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer	4
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer	4
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study	4
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer	4
Major anatomic variations of the lateral upper arm lymphatic pathway in a healthy female population	4
KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog signaling pathway	4
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies	4
Changes in CD8-positive lymphocytes following chemotherapy with concomitant bevacizumab in HER2-negative breast cancer	4
Validation of the postoperative prognostication tool PREDICT version 2.2 and 3.0 using data from the National cancer center hospital in Japan	4
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female	4
Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer	4
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan	4
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer	4
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price	4
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy	4
Time-dependent diffusion MRI for non-invasive differentiation of benign and malignant breast lesions and evaluation of proliferation index biomarkers	4
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole	4
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database	4
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community	4
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer	4
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype	3
Risk of developing subsequent primary breast cancer among non-breast cancer survivors: a retrospective cohort study	3
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer	3
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)	3
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world	3
Generalizability and reproducibility challenges in morphometric assessment of nuclear atypia in breast cancer	3
Endometrial cancer after breast cancer: caution in interpretation of risk estimates	3
Targeting breast cancer senescence in 3D models of bone metastasis	3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry	3
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro	3
Wrapping up the evidence: bandaging in breast cancer-related lymphedema—a systematic review and meta-analysis	3
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy	3
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial	3
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study	3
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry	3
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images	3
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case–control study of abemaciclib-induced interstitial lung disease (NOSIDE)	3
"Safety and efficacy of early drain removal in breast reconstruction: a retrospective cohort study"	3
Treatment and prognosis of patients with hormone receptor-low positive (1%–10%) breast cancer: a retrospective propensity score-matched analysis	3
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients	3
Association of adiponectin gene polymorphism with adipokine and lipid profile in breast cancer patients from Kano, Nigeria	3
miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway	3
Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer	3
Impact of modified dexamethasone administration sequence on infusion reaction incidence in HER2-positive breast cancer: a randomized multicenter trial	3
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1	3
tRNA modification genes are associated with genomic instability, proliferative programs, and poor prognosis in breast cancer	3
Key issues in surveillance of secondary breast cancer	3
Long-term outcomes of adjuvant radiation in elderly Asians with early stage IIA breast cancer after breast-conserving surgery: a population-based study	3
Identifying breast cancer subtypes and exploring spatial expression patterns of the key subtype-specific gene based on pathological images, single-cell sequencing, and spatial transcriptomic data	3
Adjuvant radiotherapy and survival in patients with malignant phyllode tumors: a population-based retrospective study	3
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	3
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study	3
Acknowledgments to reviewers 2022	3
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu	3
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer	3
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study	3
French national survey on breast cancer care: caregiver and patient views	3
Reply to the Letter to the editor “Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?”	3
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–	3
Macroscopic morphology of breast carcinoma: associations with biological subtypes and pathological features	3
Investigating the shared genetic architecture and causality of breast cancer and thyroid cancer: genome-wide cross trait analysis and bi-directional Mendelian randomization study	3
Artificial intelligence computer-aided detection enhances synthesized mammograms: comparison with original digital mammograms alone and in combination with tomosynthesis images in an experimental sett	2
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients	2
Presenteeism in working-age breast cancer survivors 1–5 years after surgery: relative contributions of treatment-related symptoms and modifiable factors	2
Clinical application of 90-gene expression test in a patient with occult breast cancer: a case report and literature review	2
Advances in the study of autophagy in breast cancer	2
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negati	2
A nomogram to predict the benefit of postmastectomy radiotherapy in breast cancer with nodal micrometastases	2
Postoperative complications following prepectoral versus subpectoral tissue expander placement in immediate breast reconstruction: a retrospective study from Japan	2
Prognostic impact of ER-staining patterns and heterogeneity of ER positive HER2 negative breast cancer	2
High-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imaging	2
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer	2
Conservative axillary surgery is emerging in the surgical management of breast cancer	2
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review	2
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors	2
Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosis	2
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression	2
Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2− advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-	2
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort	2
Risk of endometrial cancer among breast cancer survivors in Japan: a matched cohort study	2
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?	2
Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant breast epithelial cells through paracrine activation of PI3K–AKT pathway	2
Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility	2
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan	2
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field	2
Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing	2